Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy

Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy

Abstract Background SARS-CoV-2 viral infection is associated with a rapid and vigorous systemic inflammatory response syndrome. Soluble urokinase-type plasminogen activator receptor (suPAR) is a novel biomarker, both indicative of inflammation and propagating it. Hemoadsorption has been proposed as...

Full description

Bibliographic Details
Main Authors: Vaidas Vicka, Elija Januskeviciute, Ieva Bartuševiciene, Donata Ringaitiene, Aiste Aleknaviciene, Mindaugas Serpytis, Laurynas Rimsevicius, Marius Miglinas, Ligita Jancoriene, Jurate Sipylaite
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Nephrology
Subjects:
Renal replacement therapy
SuPAR
Hemoadsrobtion
Online Access:https://doi.org/10.1186/s12882-022-03003-2

Internet

https://doi.org/10.1186/s12882-022-03003-2

Similar Items